IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EUNICE A OKORO

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1346267770
CMS profile
11087187
Location
SPRINGFIELD, VA

General Payments · PY2021–2024

$4,307.36

  • Reported across 192 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,396.68

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health VA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,289.91 48
Education $106.77 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $337.91 7
Teva Pharmaceuticals USA, Inc. $294.05 8
ITI, Inc. $207.38 12
Janssen Pharmaceuticals, Inc $172.18 7
Supernus Pharmaceuticals, Inc. $138.33 5
Alkermes, Inc. $58.79 3
E.R. Squibb & Sons, L.L.C. $55.32 2
Almatica Pharma Inc. $43.26 2
ABBVIE INC. $40.14 2
Neurocrine BioSciences, Inc. $33.25 1
Otsuka America Pharmaceutical, Inc. $16.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $996.50 49
PY2022 $747.52 39
PY2023 $1,166.66 54
PY2024 $1,396.68 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.22 01/26/2024 Food and Beverage Undisputed 01/23/2026 1107759792 CMS
ABBVIE INC. $23.92 02/06/2024 Food and Beverage Undisputed 01/23/2026 1107759794 CMS
Alkermes, Inc. $18.38 04/11/2024 Food and Beverage Undisputed 01/23/2026 1120565910 CMS
Alkermes, Inc. $25.38 05/31/2024 Food and Beverage Undisputed 01/23/2026 1120565912 CMS
Alkermes, Inc. $15.03 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120565914 CMS
Almatica Pharma LLC $20.88 02/16/2024 Food and Beverage Undisputed 01/23/2026 1137610860 CMS
Almatica Pharma LLC $22.38 03/07/2024 Food and Beverage Undisputed 01/23/2026 1137610865 CMS
E.R. Squibb & Sons, L.L.C. $27.27 10/17/2024 Education Undisputed 01/23/2026 1101450187 CMS
E.R. Squibb & Sons, L.L.C. $28.05 10/17/2024 Food and Beverage Undisputed 01/23/2026 1101450195 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.32 02/15/2024 Food and Beverage Undisputed 01/23/2026 1143574181 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.13 03/14/2024 Food and Beverage Undisputed 01/23/2026 1143574183 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.48 04/24/2024 Food and Beverage Undisputed 01/23/2026 1143574185 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.90 05/29/2024 Food and Beverage Undisputed 01/23/2026 1143574187 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.06 06/03/2024 Food and Beverage Undisputed 01/23/2026 1143574189 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.19 07/31/2024 Food and Beverage Undisputed 01/23/2026 1143574191 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.97 08/14/2024 Food and Beverage Undisputed 01/23/2026 1143574193 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.84 09/12/2024 Food and Beverage Undisputed 01/23/2026 1143574195 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.19 09/24/2024 Food and Beverage Undisputed 01/23/2026 1143574197 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.28 10/17/2024 Food and Beverage Undisputed 01/23/2026 1143574199 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.71 11/15/2024 Food and Beverage Undisputed 01/23/2026 1143574201 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.31 12/07/2024 Food and Beverage Undisputed 01/23/2026 1143574203 CMS
Janssen Pharmaceuticals, Inc $15.26 02/21/2024 Food and Beverage Undisputed 01/23/2026 1078242731 CMS
Janssen Pharmaceuticals, Inc $28.56 03/13/2024 Food and Beverage Undisputed 01/23/2026 1078242763 CMS
Janssen Pharmaceuticals, Inc $21.78 04/25/2024 Food and Beverage Undisputed 01/23/2026 1078242739 CMS
Janssen Pharmaceuticals, Inc $38.69 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078242733 CMS
Janssen Pharmaceuticals, Inc $3.35 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078242773 CMS
Janssen Pharmaceuticals, Inc $27.03 07/24/2024 Food and Beverage Undisputed 01/23/2026 1078242771 CMS
Janssen Pharmaceuticals, Inc $37.51 09/17/2024 Food and Beverage Undisputed 01/23/2026 1078242757 CMS
Neurocrine Biosciences, Inc. $33.25 11/16/2024 Food and Beverage Undisputed 01/23/2026 1150934090 CMS
Otsuka America Pharmaceutical, Inc. $16.07 03/25/2024 Food and Beverage Undisputed 01/23/2026 1119153567 CMS
Supernus Pharmaceuticals, Inc. $118.62 08/06/2024 Food and Beverage Undisputed 01/23/2026 1147872753 CMS
Supernus Pharmaceuticals, Inc. $4.63 08/21/2024 Food and Beverage Undisputed 01/23/2026 1147872749 CMS
Supernus Pharmaceuticals, Inc. $8.05 08/21/2024 Food and Beverage Undisputed 01/23/2026 1147872751 CMS
Supernus Pharmaceuticals, Inc. $2.59 10/10/2024 Food and Beverage Undisputed 01/23/2026 1147872745 CMS
Supernus Pharmaceuticals, Inc. $4.44 10/10/2024 Food and Beverage Undisputed 01/23/2026 1147872747 CMS
Teva Pharmaceuticals USA, Inc. $11.64 02/01/2024 Food and Beverage Undisputed 01/23/2026 1151710115 CMS
Teva Pharmaceuticals USA, Inc. $120.23 02/08/2024 Food and Beverage Undisputed 01/23/2026 1151710131 CMS
Teva Pharmaceuticals USA, Inc. $24.47 03/25/2024 Food and Beverage Undisputed 01/23/2026 1151710139 CMS
Teva Pharmaceuticals USA, Inc. $1.60 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151710163 CMS
Teva Pharmaceuticals USA, Inc. $13.97 04/17/2024 Food and Beverage Undisputed 01/23/2026 1151710175 CMS
Teva Pharmaceuticals USA, Inc. $23.03 05/08/2024 Food and Beverage Undisputed 01/23/2026 1151710177 CMS
Teva Pharmaceuticals USA, Inc. $79.50 05/08/2024 Education Undisputed 01/23/2026 1151710233 CMS
Teva Pharmaceuticals USA, Inc. $19.61 06/19/2024 Food and Beverage Undisputed 01/23/2026 1151710187 CMS
Vanda Pharmaceuticals Inc. $17.29 02/22/2024 Food and Beverage Undisputed 01/23/2026 1133961931 CMS
Vanda Pharmaceuticals Inc. $113.21 04/23/2024 Food and Beverage Undisputed 01/23/2026 1133961933 CMS
Vanda Pharmaceuticals Inc. $37.08 06/05/2024 Food and Beverage Undisputed 01/23/2026 1133961935 CMS
Vanda Pharmaceuticals Inc. $15.12 08/15/2024 Food and Beverage Undisputed 01/23/2026 1133961937 CMS
Vanda Pharmaceuticals Inc. $107.93 09/10/2024 Food and Beverage Undisputed 01/23/2026 1133961939 CMS
Vanda Pharmaceuticals Inc. $21.40 09/26/2024 Food and Beverage Undisputed 01/23/2026 1133961941 CMS
Vanda Pharmaceuticals Inc. $25.88 10/02/2024 Food and Beverage Undisputed 01/23/2026 1133961943 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.